Overview and Scope
Antibiotics are a class of medications that work by either killing bacteria or inhibiting their growth, helping the body’s immune system eliminate the infection. Antibiotics are used in the treatment of various infections caused by bacteria.
Sizing and Forecast
The antibiotics market size has grown strongly in recent years. It will grow from $80.01 billion in 2023 to $84.54 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increased incidence of infectious diseases, growing population and urbanization, rising healthcare awareness, access to healthcare services, prevalence of antibiotic-resistant strains..
The antibiotics market size is expected to see strong growth in the next few years. It will grow to $105.73 billion in 2028 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to global health threats, rising healthcare expenditure, government initiatives and regulations, increased international collaboration.. Major trends in the forecast period include development of oral antibiotics, collaboration and partnerships for antibiotic development, regulatory incentives and pathways, antimicrobial stewardship programs in healthcare, global health initiatives for antibiotic access..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report
Segmentation & Regional Insights
The antibiotics market covered in this report is segmented –
1) By Drug Class: Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, Other Classes
2) By Spectrum Of Activity: Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic
3) By Route Of Administration: Oral, Intravenous, Other Routes
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By Application: Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, Other Applications
North America was the largest region in the antibiotics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11923&type=smp
Major Driver Impacting Market Growth
The rising prevalence of bacterial infections is expected to drive the antibiotics market going forward. Bacterial infections refer to infections caused by bacteria, which are microscopic single-celled organisms. Antibiotics are extremely helpful in the treatment and prevention of bacterial diseases because they prevent the growth of bacteria. For instance, in February 2023, according to the World Health Organization, a Switzerland-based specialized health agency of the United States, 30 countries in the world were suffering from a cholera epidemic in 2022. The case fatality ratio (CFR) of cholera was 1.9% in 2021, which was the highest recorded in a decade. Additionally, in April 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, syphilis cases in the United States increased by 32% in 2021 as compared to 2020. As a result, the rising prevalence of bacterial infections is driving the antibiotics market.
Key Industry Players
Major companies operating in the antibiotics market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb (BMS), AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim, Viatris Inc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Sun Pharmaceutical Industries Limited, Cipla Ltd., Ferring Pharmaceuticals, Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Spero Therapeutics Inc., Nabriva Therapeutics Plc
The antibiotics market report table of contents includes:
1. Executive Summary
2. Antibiotics Market Characteristics
3. Antibiotics Market Trends And Strategies
4. Antibiotics Market – Macro Economic Scenario
5. Global Antibiotics Market Size and Growth
……………………
32. Global Antibiotics Market Competitive Benchmarking
33. Global Antibiotics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Antibiotics Market
35. Antibiotics Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
